We are offering on a best efforts basis 4,473,000 shares of our common stock in this offering pursuant to this prospectus supplement and the accompanying prospectus at a price of $0.38 per share.

 

Our common stock is listed on the Nasdaq Capital Market under the symbol "VEEE." On March 16, 2026, the last reported sale price of our common stock on the Nasdaq Capital Market was $0.35 per share.

We are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 and a "smaller reporting company." As such, we have elected to comply with certain reduced public company reporting requirements. Please see "Prospectus Supplement Summary—Implications of Being an Emerging Growth Company."

Investing in our common stock involves a high degree of risk. Before making an investment decision, please read the information under the heading "Risk Factors" beginning on page S-9 of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and the accompanying base prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying base prospectus. Any representation to the contrary is a criminal offense.

As of the date of this prospectus supplement, the aggregate market value of our common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 is $14,099,353, which is calculated based on 8,197,298 shares of our common stock outstanding held by non-affiliates and a price of $1.72 per share, the closing price of our common stock on January 26, 2026, which is the highest closing sale price of our common stock on the Nasdaq Capital Market within the prior 60 days of this prospectus supplement. During the prior 12 calendar month period that ends on and includes the date hereof, we have not offered or sold any shares of our common stock pursuant to General Instruction I.B.6 to Form S-3.